Clinical Trials Browser

Interventional × Klatskin Tumor × Radiosurgery × Clear all

NCT06493734 2025-07-15

STRONG II

Phase NA Recruiting

Gastrointestinal

Klatskin Tumor

NCT07030140 2025-06-22

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT03307538 2021-01-26

STRONG

Phase NA Completed

Gastrointestinal

Klatskin Tumor